Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors
- PMID: 6207441
- DOI: 10.1007/BF00501435
Clonidine inhibits salivary secretion by activation of postsynaptic alpha 2-receptors
Abstract
The effects of clonidine on the submaxillary gland of the rat were studied. Doses ranging between 100 to 3.000 micrograms/kg produced a sustained secretory response which was blocked by 0.1 mg/kg of prazosin but not by 1 mg/kg of yohimbine. Clonidine 10 micrograms/kg markedly inhibited the salivation induced by noradrenaline, methacholine and substance P but not that induced by isoproterenol. The inhibition caused by the alpha 2-agonist was greater for noradrenaline than for either methacholine or substance P. Blockade of alpha 2 adrenoceptors with yohimbine (0.3 - 1 mg/kg) prevented the inhibition by clonidine of noradrenaline, methacholine and substance P induced salivation. On the other hand, prazosin 0.1 mg/kg did not modify the inhibition by clonidine of methacholine induced secretion. The results obtained indicate that clonidine exerts a dual effect on salivary secretion: at high doses it elicits salivation through activation of alpha 1-adrenoceptors; at the dose of 10 micrograms/kg clonidine activates alpha 2-adrenoceptors which inhibit the secretory response evoked through either muscarine, substance P and alpha 1-adrenoceptor agonists.
Similar articles
-
Effects of guanabenz and guanfacine on postsynaptic alpha 2-adrenoceptors in the rat submaxillary and parotid glands.Naunyn Schmiedebergs Arch Pharmacol. 1985 May;329(3):289-92. doi: 10.1007/BF00501882. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2862591
-
Physiological role of alpha-adrenoceptors in salivary secretion.Acta Odontol Latinoam. 1990;5(1):31-8. Acta Odontol Latinoam. 1990. PMID: 1963779
-
Sympathetic and parasympathetic nerves regulate postsynaptic alpha-2 adrenoceptor in salivary glands.J Pharmacol Exp Ther. 1986 Nov;239(2):488-93. J Pharmacol Exp Ther. 1986. PMID: 3021956
-
Blockade of postsynaptic alpha 2-adrenoceptors enhances responses to mixed alpha 1/alpha 2-agonists in rat submaxillary gland.Eur J Pharmacol. 1986 Feb 18;121(2):245-9. doi: 10.1016/0014-2999(86)90495-4. Eur J Pharmacol. 1986. PMID: 2870928
-
Challenge tests: assessment of the noradrenergic and GABA systems in depression and anxiety disorders.Mol Aspects Med. 1992;13(3):221-47. doi: 10.1016/0098-2997(92)90011-n. Mol Aspects Med. 1992. PMID: 1331646 Review. No abstract available.
Cited by
-
Effects of guanabenz and guanfacine on postsynaptic alpha 2-adrenoceptors in the rat submaxillary and parotid glands.Naunyn Schmiedebergs Arch Pharmacol. 1985 May;329(3):289-92. doi: 10.1007/BF00501882. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2862591
-
Clinical profile of clozapine: adverse reactions and agranulocytosis.Psychiatr Q. 1992 Spring;63(1):51-70. doi: 10.1007/BF01064682. Psychiatr Q. 1992. PMID: 1438605 Review.
-
Effects of yohimbine on submaxillary salivation in dogs.Br J Pharmacol. 1989 Sep;98(1):101-4. doi: 10.1111/j.1476-5381.1989.tb16868.x. Br J Pharmacol. 1989. PMID: 2804539 Free PMC article.
-
Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.Curr Neuropharmacol. 2008 Sep;6(3):254-85. doi: 10.2174/157015908785777193. Curr Neuropharmacol. 2008. PMID: 19506724 Free PMC article.
-
Salivary gland function, development, and regeneration.Physiol Rev. 2022 Jul 1;102(3):1495-1552. doi: 10.1152/physrev.00015.2021. Epub 2022 Mar 28. Physiol Rev. 2022. PMID: 35343828 Free PMC article. Review.